Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Provider Statement: This continuing medical education activity is provided by 
.
Support Statement: This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
There is no non-commercial support for this activity.
Target Audience: The intended audience for the activity is gastroenterology nurses, nurse practitioners, physician assistants, and other health care professionals involved in the treatment of patients with IBD.
Purpose/Learning Objectives: Upon successful completion of this educational activity, participants should be better able to:
- Examine the pathophysiology of inflammatory bowel disease to better understand how specific therapies aid in the treatment of mild-to-severe disease.
- Describe diagnostic modalities and assessment tools that may improve the early diagnosis of inflammatory bowel disease.
- Evaluate medical advances for patients with inflammatory bowel disease that may improve patient management and outcomes.
Activity Co-Chairs:
Russell D. Cohen, MD, FACG, AGAF
Professor of Medicine, Pritzker School of Medicine
Director, Inflammatory Bowel Disease Center
University of Chicago Medicine
Chicago, IL
David T. Rubin, MD, FACG, AGAF, FACP, FASGE
Joseph B. Kirsner Professor of Medicine
Section Chief, Gastroenterology, Hepatology and Nutrition
Inflammatory Bowel Disease Center
University of Chicago Medicine
Chicago, IL
Nurse Information:
Vindico Medical Education, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's (ANCC’s) Commission on Accreditation.
This activity is approved for 1.5 contact hour(s) of continuing education by the American Association of Nurse Practitioners.
Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.
Nurse Practitioner Information:
This activity is approved for 1.5 contact hour(s) of continuing education (which includes 0.5 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 16112444. This activity was planned in accordance with AANP CE Standards and Policies.
Physician Assistant Information:
This program has been reviewed and is approved for a maximum of 1.50 AAPA Category 1 CME credits by the PA Review Panel. PAs should claim only the credit commensurate with the extent of their participation in the activity.
This program was planned in accordance with AAPA’s CME Standards for Enduring Programs and for Commercial Support of Enduring Programs.
This enduring material was originally approved for 1 year from the date of original release, February 20, 2017 through February 19, 2018. It has since been recertified for an additional year and will now expire on January 29, 2019.
How to Participate in this Activity and Obtain CE Credit:
To participate in this CE activity, you must read the objectives, answer the pretest, review the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 3 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue a credit certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education and the American Nurses Credentialing Center’s Standards for Commercial Support, all CE providers are required to disclose to the activity audience the relevant financial relationship of the planners, teachers, and authors involved in the development of CE content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CE activity content over which the individual has control. Relationship information appears above.
Activity Co-Chairs and Planning Committee report the following relationship(s) which are accurate at the time of original content release (2/20/2017):
Russell D. Cohen, MD, FACG, AGAF
Consulting Fee: AbbVie Laboratories, Celgene, Entera Health, Hospira, Janssen (Johnson & Johnson / Centocor), Pfizer, Sandoz Biopharmaceuticals, Takeda, UCB Pharma
Contracted Research: AstraZeneca, Celgene, Gilead Sciences, Medimmune, Mesoblast Ltd., Osiris Therapeutics, Pfizer, Receptos, RedHill Biopharma, Sanofi-Aventis, UCB Pharma
David T. Rubin, MD, FACG, AGAF, FACP, FASGE
Consulting Fee: AbbVie, Amgen, Emmi, Genentech, Janssen, Pfizer, Shire, Takeda, UCB Pharma
Contracted Research: AbbVie, Amgen, Genentech, Janssen, Prometheus, Shire, Takeda, UCB Pharma
Board of Trustees: American College of Gastroenterology; Co-Founder: Cornerstones Health, Inc., GoDuRn, LLC
Mary Ayers, BSN-RN
Speakers Bureau: AbbVie
Ashley A. Bochenek, APN, FNP-BC
Consulting Fee: Takeda
Speakers Bureau: AbbVie, Janssen
Janice C. Colwell, APRN, CWOCN, FAAN
Speakers Bureau Coloplast, Hollister
Michele Rubin, MSN,APN,CNS,CGRN
No relevant financial relationships to disclose.
Reviewers report the following relationships:
Linda A. Giarraputo, PA-C
No relevant financial relationships to disclose.
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP (Recertification review on 1/29/2018)
No relevant financial relationships to disclose.
Nurse Planners:
Barbara A. Niedz, PhD, RN, CPHQ
No relevant financial relationships to disclose.
Natalie Wilson, MS, RN
No relevant financial relationships to disclose.
Vindico staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2017 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CE Questions?
Contact us at cme@vindicoCME.com